Ultragenyx Pharmaceutical Inc. (52) | Separation Agreements (1)
- Separation Agreement and General Release between Wladimir Hogenhuis, M.D. and Ultragenyx Pharmaceutical Inc., dated November 22, 2019 (Filed With SEC on November 25, 2019)
© 2022 Justia
